| Dr Sara Elizabeth Timmons, PHD, LMFT | |
|
1650 Kendale Blvd, Suite 95, East Lansing, MI 48823-2076 | |
| (219) 742-9167 | |
| (517) 489-4444 |
| Full Name | Dr Sara Elizabeth Timmons |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 1650 Kendale Blvd, East Lansing, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629377585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 4101006428 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sara Elizabeth Timmons, PHD, LMFT 1650 Kendale Blvd, Suite 95, East Lansing, MI 48823-2076 Ph: () - | Dr Sara Elizabeth Timmons, PHD, LMFT 1650 Kendale Blvd, Suite 95, East Lansing, MI 48823-2076 Ph: (219) 742-9167 |
News Archive
ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, announced today new preclinical data from two separate studies of darinaparsin, a novel organic arsenic, in various solid tumor models at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, taking place November 12-16 in San Francisco.
Our immune systems are made up of billions of white blood cells searching for signs of infections and foreign invaders, ready to raise the alarm.
Healthy adults with higher levels of phosphate in the blood are more likely to have increased levels of calcium in the coronary arteries-a key indicator of atherosclerosis and future cardiovascular disease risk, reports a study in the February 2009 issue of the Journal of the American Society of Nephrology (JASN).
AstraZeneca and Targacept, Inc. today announced top-line results from the remaining Phase 3 studies investigating efficacy, tolerability and safety of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who did not respond adequately to initial antidepressant treatment.
Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited announced today that the United States Food and Drug Administration (FDA) has issued a complete response letter dated January 31, 2011 regarding the New Drug Application for Contrave® (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.
› Verified 3 days ago
Kathryn Stevenson, MFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1422 W Saginaw St, East Lansing, MI 48823 Phone: 510-393-3360 | |
Mrs. Veronica Thelen, MS/LLMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5031 Park Lake Rd, East Lansing, MI 48823 Phone: 517-332-0811 Fax: 517-332-4452 | |
Rachel Recker, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 200 Woodland Pass, Suite E, East Lansing, MI 48823 Phone: 517-449-4875 Fax: 517-657-3684 | |
Mr. Karlin James Tichenor, MA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 138 Service Rd, East Lansing, MI 48824 Phone: 517-432-2272 | |
Mr. Timothy Welch, MS Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1550 Watertower Pl, East Lansing, MI 48823 Phone: 918-383-0547 | |
Mrs. Sarah Gonzalez, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2970 E Lake Lansing Rd, East Lansing, MI 48823 Phone: 517-230-5695 Fax: 855-978-1293 | |
Erica Nordquist, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1422 W Saginaw St, East Lansing, MI 48823 Phone: 269-598-1579 |